Merck Serono Movectro
Europe committee rejects MS treatment Movectro
September 24, 2010Sales and Marketing Cladribine, Merck Serono Movectro
The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
